ZEB2 and cancer: These miRNAs exhibit tumor suppressor activity to antagonize EMT associated with cancer metastasis by silencing E-cadherin, such as ZEB1 and ZEB2 in various cancers such as colorectal cancer [98], gastric cancer [99], pancreatic cancer [100], ovarian cancer [101], and nasopharyngeal cancer [102].